-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Financial App News, Jianyou Co., Ltd. (603707.SH) announced that EmergeBiosciencepte.Ltd. (hereinafter referred to as “Emerge”), a wholly-owned subsidiary of the company, recently received approval for adalimumab injection (40mg/0.4 mL, 80mg/0.8 mL) (BLA number: 761216) issued by the US Food and Drug Administration (“US FDA”).

Zhitongcaijing·09/29/2026 08:17:14
Listen to the news
Zhitong Financial App News, Jianyou Co., Ltd. (603707.SH) announced that EmergeBiosciencepte.Ltd. (hereinafter referred to as “Emerge”), a wholly-owned subsidiary of the company, recently received approval for adalimumab injection (40mg/0.4 mL, 80mg/0.8 mL) (BLA number: 761216) issued by the US Food and Drug Administration (“US FDA”).